FDA to discuss Johnson and Johnson booster

An FDA advisory panel will meet Friday to discuss the Johnson & Johnson coronavirus booster shot and whether or not to approve it. This comes after the same panel voted Thursday to approve a third dose of the Moderna vaccine for high-risk adults.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting